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IMPORTANCE Handheld spectral-domain optical coherence tomography (SD-OCT) can

provide insights into the complex interactions occurring at the vitreoretinal interface in
retinopathy of prematurity (ROP) to enhance our understanding of ROP pathology.
OBJECTIVE To characterize vitreous bands in premature infants with use of handheld SD-OCT.
DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study conducted from July 7, 2015,
to February 28, 2017, at 2 university-based neonatal intensive care units. Seventy-three
premature infants who required routine ROP screening examination were recruited. Informed
consent was obtained from all legal guardians. Trained graders who were masked to the
clinical assessment analyzed each SD-OCT scan of the right eye for vitreoretinal findings.
A third trained grader mediated disagreements.
MAIN OUTCOMES AND MEASURES Associations between the presence of vitreous bands in
premature infants with ROP diagnoses and the presence of other vitreoretinal SD-OCT
findings were investigated.
RESULTS Of the 73 infants recruited, 6 infants’ parents withdrew their children from the
study, and 2 infants were too hemodynamically unstable for imaging, leaving a total of 65
participants. Of these, 32 (49%) were female, 36 (55%) were white, 10 (15%) were Hispanic,
3 (5%) were Native American, 4 (6%) were African American, 4 (7%) were Asian/Pacific
Islander, and 8 (12%) were other. The mean (SD) gestational age was 28 (2.7) weeks, the
mean (SD) birth weight was 997 g (286 g), and the mean (SD) postmenstrual age at imaging
was 34 (3) weeks (mean [SD] total of 3 [2] imaging sessions). Comparing the 24 infants (37%)
who had a right eye vitreous band at any time with the 41 (63%) who did not, no difference in
mean birth weight, gestational age, postmenstrual age at imaging, sex, or race/ethnicity was
identified. No associations with ROP stage (eg, in 6 [25%] infants with vitreous bands vs
4 [9.8%] in those without; P = .23), presence of plus disease (2 [8%] vs 2 [5%]; P = .84), or
type 1 ROP (3 [12%] vs 3 [7%]; P = .66) were identified. Vitreous bands were associated with
epiretinal membrane detected on SD-OCT (P = .001) with an odds ratio of 9.4 (95% CI,
2.8-31.3) in 15 [62%] infants with vitreous bands vs 6 [15%] in those without. Vitreous bands
were also associated with cystoid macular edema (in 15 [62%] infants with vitreous bands
vs 1 [27%] in those without; P = .005) with an odds ratio of 4.5 (95% CI, 1.5-13.3).
CONCLUSIONS AND RELEVANCE In this study, the development of vitreous bands was
associated with both cystoid macular edema and epiretinal membrane. These findings
suggest a tractional pathogenesis to these entities among premature infants. This study did
not find a direct association between vitreous bands and severe ROP. Additional study is
needed to determine whether vitreous bands represent subclinical hyaloidal organization
leading to retinal detachment in advanced ROP.
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D

espite advances in neonatal care, retinopathy of
prematurity (ROP) continues to be a major cause of
vision loss in the United States.1 Fundus examination
with indirect ophthalmoscopy remains the criterion standard for screening and monitoring patients with ROP.2 Even
when strict screening protocols are followed, ROP can still
progress to retinal detachment. Advanced ROP (stage 4 and 5
disease) is heralded by fibrovascular traction and usually requires surgical intervention. 3 Timely identification and
treatment of infants with fibrovascular proliferation is
essential for halting the devastating vision loss accompanying
ROP-associated retinal detachment.
Handheld spectral-domain optical coherence tomography (SD-OCT), which allows for in vivo detailed imaging of
the retinal microarchitecture in the supine position, is gaining popularity for use among the infant population. Several
earlier studies have demonstrated occult features of the
retina in infants screened for ROP. Examination with
SD-OCT can identify epiretinal membrane (ERM), cystoid
macular edema (CME), retinoschisis, intraretinal deposits,
and macular detachments that are not detected on clinical
examination by experienced ROP screeners.4-9 At present,
there is a paucity of literature regarding vitreous SD-OCT
findings in premature infants.
Vitreous bands visualized during vitrectomy procedures
in advanced ROP are typically targeted to release tractional
retinal detachment.10 Handheld SD-OCT may identify such
bands or their precursors. Even for those infants who obtain
a good anatomic outcome, vitreous pathologic features
related to ROP may linger for many years. Studies have
shown that patients with a history of ROP are known to have
worse visual outcomes than age-matched infants without
ROP. 1 1 ,1 2 Occult CME and ERM may play a role in the
decreased vision observed in this population.9,12,13 Furthermore, longitudinal data on adults with a history of ROP show
that these patients have a high risk for premature cataract
formation, 14,15 glaucoma, 16-19 retinal tears, 20 and retinal
detachments,21-23 all of which may in part result from vitreous abnormalities. Some studies suggest that these complications occur with greater frequency with increasing severity of ROP,15,19 yet severe complications can occur even in
patients with regressed disease that never required
treatment.20,24 This study sought to characterize vitreous
bands in premature infants by using handheld SD-OCT and
to evaluate whether these bands are associated with worsening ROP stage or other vitreoretinal pathologies.

Methods
This prospective, observational study was approved by the
institutional review board at Seattle Children’s Hospital and the
University of Washington (Seattle, Washington). Informed consent was obtained from the legal guardians of the neonates
while in the neonatal intensive care unit (NICU) of 2 university
hospitals: Seattle Children’s Hospital and the University of
Washington Medical Center. Handheld SD-OCT was performed
at the time of each routine ROP screening examination.
754

Key Points
Question What is the potential importance of vitreous bands
detected with handheld spectral-domain optical coherence
tomography among premature infants screened for retinopathy
of prematurity?
Findings In this cohort study of 65 premature infants, 37% had
vitreous bands detected with handheld spectral-domain optical
coherence tomography. Vitreous bands were associated with
epiretinal membranes and cystoid macular edema but not with
advanced retinopathy of prematurity.
Meaning Vitreous bands may represent posterior vitreous
abnormalities contributing to the development of cystoid macular
edema and epiretinal membrane among premature infants.

Study Participants
Necessity of initial clinical examination was defined as less than
30 weeks’ gestation, less than a 1500-g birth weight, and selected infants with a birth weight between 1500 and 2000 g
or gestational age of more than 30 weeks with an unstable clinical course, including those neonates who required cardiorespiratory support. Infants whose medical condition was too unstable to have SD-OCT imaging or examination were excluded
from the study. Each infant’s pupil was dilated with an ophthalmic solution containing phenylephrine hydrochloride, 1%,
and cyclopentolate, 0.2% (Cyclomydril; Alcon Laboratories).

Imaging Procedure
Imaging was performed using a handheld SD-OCT (Envisu C2300;
Leica Microsystems) with the patient in the supine position without anesthesia and most often without an eyelid speculum as described by Maldonado et al.25 All SD-OCT scans were obtained
by 1 of 2 trained imagers (A.S. and L.G.). Sucrose solution or a pacifier was occasionally used to soothe the infant during imaging.
The SD-OCT scans were obtained each time an enrolled infant
required a clinical screening ROP examination. The scans were
performed with special attention to the posterior pole, with the
goal being to capture the highest-quality fovea and optic nerve
images using multiple individual volume scans.

ROP Screening and Data Collection
Infants underwent their usual indirect ophthalmoscopic clinical examination by 1 of 3 pediatric ophthalmologists (including K.T.-H. and M.T.C.) after SD-OCT imaging on the same day
that SD-OCT imaging was performed. The ophthalmologist
who performed the clinical examination was masked to the
SD-OCT findings. All clinical observations, follow-up, and treatment decisions were made independently of SD-OCT findings and according to standard ROP screening and treatment
guidelines.2 Each infant’s medical record was reviewed for
baseline demographic characteristics (gestational age, birth
weight, sex, and race/ethnicity), ROP diagnoses, and any mention of vitreous findings based on the clinical indirect
ophthalmoscopic examination.

Image Analysis
Two trained graders (A.S. and E.M.Z.) evaluated each
SD-OCT scan of the right eye using the imaging system’s
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software (Envivovue; Leica Microsystems) while masked to the
clinical assessment. The graders had access to all complete volume scans obtained on each day the participant had an ROP
screening clinical examination. The highest-quality foveal and
optic nerve volume scans were graded for both retinal and vitreous findings. Additional volume scans were reviewed for any
unusual findings not present in the first 2 volume scans. Retinal findings included CME and ERM. A finding of CME was defined as intraretinal hyporeflective spaces that distorted the
normal architecture of the retina and were seen in more than
1 frame. A finding of ERM was defined as a distinct linear hyperreflective band at the vitreoretinal interface, with some
separation from the retinal surface outside the hyperreflective artifact often seen overlying the retinal vessels. Vitreous
findings included punctate hyperreflective opacities and vitreous bands. Punctate hyperreflective opacities were identified as multiple discreet hyperreflective opacities in the vitreous visible above background. Vitreous bands were
coalescing linear opacities hovering over the retina that were
visible in at least 3 consecutive frames with intensity above the
background. Vitreous bands were divided into tractional and
nontractional bands. Tractional vitreous bands were described as straight bands at a steep angle that made a connection to the retinal surface. Nontractional bands did not appear to have a connection to the retina in the frames captured
by the scan and hovered parallel over the retina. Disagreement between the 2 readers in any of the above analysis was
mediated by a third trained reader (M.T.C.).

Original Investigation Research

drawn from the study by their guardians, who perceived the examination as too stressful for the infant. Two infants missed their
imaging sessions because of hemodynamic instability. The remaining 65 infants were included in the analysis, of whom 33
of 65 (51%) were male; the infants had a mean (SD) birth weight
of 997 (286) g and a mean (SD) gestational age of 28 (2.7) weeks.
The mean (SD) postmenstrual age at imaging was 34 (3) weeks.
Of 65 infants, 36 (55%) were white, 10 (15%) were Hispanic, 3
(5%) were Native American, 4 (6%) were African American, 1
(2%) was Pacific Islander, 3 (5%) were Asian, and 8 (12%) were
other. Among the 65 infants for whom images were obtained,
there were 209 total ROP screening examinations and imaging
sessions involving the right eye with a mean (SD) of 3 (2) ROP
screenings and imaging sessions per participant.

Clinical Examination Findings
On clinical examination, 22 of the 65 infants (34%) received a
diagnosis of ROP, and only 6 of 65 (9%) received a diagnosis of
type 1 ROP requiring treatment. All of these infants were treated
with laser photocoagulation. The worst ROP stage observed on
clinical examination was stage 3 ROP, which was diagnosed in
19 of 209 clinical examinations (9%). The most frequent stage
observed was stage 0, which was identified in 117 of 209 clinical examinations (56%). The clinician made note of “vitreous
findings” in only 6 of 209 clinical examinations (3%). The findings described were vitreous haze in 5 examinations (2%) and
frank vitreous hemorrhage in 1 examination (1%).

Vitreous Findings by Handheld SD-OCT
Statistical Analysis
Only findings of examinations of the right eye were included
in the analysis. Infants who had ever developed vitreous bands
in their right eye were compared with infants who had not developed vitreous bands for presence or absence of clinically
determined ROP, type 1 ROP,26 worst ROP stage, worst plus
disease status, vitreous haze or hemorrhage, birth weight,
gestational age, and other SD-OCT findings (development of
hyperreflective vitreous opacities, CME, or ERM in that eye at
any time). Separate analyses were performed for the above
comparisons using the subcategories of tractional vitreous band
and nontractional vitreous band.
The Shapiro-Wilk test of normality showed that birth
weight and gestational age at birth were not normally distributed; thus, data analysis comparing the groups was performed using the nonparametric Mann-Whitney test for continuous variables. All categorical data were analyzed using
either the χ2 test or the Fisher exact test. The unweighted
Cohen κ statistic was applied to assess the strength of interobserver agreement. Statistical analyses were performed using
SAS, version 9.4 (SAS Institute, Inc). A 2-sided value of
P < .05 was considered statistically significant.

Results
Subject Characteristics
Seventy-three premature infants were recruited for the study,
of whom 8 were excluded. Six of these infants were withjamaophthalmology.com

The 2 trained graders agreed on 188 of 209 SD-OCT scans (90%).
The Cohen κ score was 0.8 (95% CI, 0.74-0.94). Of the 21 cases
in which the scores provided by the trained graders disagreed,
10 (48%) of the disagreements were owing to differing opinions on the presence of ERM vs a normal hyperreflective nerve
fiber layer, and 7 (33%) were attributable to disagreement on the
presence of small intraretinal cysts vs normal reflective variability in darker scans. The readers disagreed regarding vitreous bands only 4 times (19%) with disagreement secondary to
a question of hyperreflective artifact. The 2 readers agreed in
all cases involving punctate hyperreflective opacities.
Findings of either vitreous bands or punctate hyperreflective vitreous opacities (Figure 1) occurred in 86 of 209 imaging
sessions (41%) among 46 of 65 participants (71%). Among the
65 study participants, 24 (37%) had evidence of a vitreous band
at least once during all imaging sessions involving the right eye.
The more frequent finding was a nontractional band (Figure 2),
which occurred in 32 of 209 imaging sessions (15%) among 22
of 65 participants (34%). A vitreous tractional band (Figure 3)
was observed in 8 of 209 imaging sessions (4%) among 5 of 65
enrolled infants (8%). The punctate hyperreflective vitreous
opacities occurred in 46 of 209 imaging sessions (22%) obtained for 19 of 65 study participants (29%). The vitreous bands
(including both subtypes) and the punctate hyperreflective
vitreous opacities occurred together in 9 of 209 imaging sessions (4%) in 7 of 65 study participants (11%) (P = .26).
The presence of a vitreous band was associated with the
presence of an ERM observed on SD-OCT (in 15 [62%] infants
with vitreous bands vs 6 [15%] in those without; P = .001)
(Reprinted) JAMA Ophthalmology July 2018 Volume 136, Number 7
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Figure 1. Handheld Spectral-Domain Optical Coherence Tomography
of Hyperreflective Vitreous Opacities

Figure 2. Handheld Spectral-Domain Optical Coherence Tomography
of Nontractional Vitreous Band

Image obtained from a study participant with stage 1 retinopathy of prematurity
showing multiple discrete, punctate hyperreflective opacities hovering above the
retina. Punctate hyperreflective opacities were present in 19 of 65 scans (29%)
obtained from premature infants screened for retinopathy of prematurity.

(Table). A neonate was 9 times more likely to have a vitreous
band when an ERM was also present than when an ERM was
not present (odds ratio, 9.4; 95% CI, 2.8-31.3). In the infants
who developed an ERM, this finding was seen most commonly (7 of 19 infants; 37%) between 32 and 34 weeks’ postmenstrual age. Cystoid macular edema was also associated with
vitreous bands (in 15 [62%] infants with vitreous bands vs 11
[27%] in those without; P = .005) (Table). When CME was
present on the SD-OCT image, a vitreous band was 5 times more
likely to be observed (odds ratio, 4.6; 95% CI, 1.5-13.3). For those
neonates who developed CME, this finding was most commonly present (9 of 23 infants; 39%) at 33 to 35 weeks postmenstrual age.
Twenty-four of 65 study participants (37%) had a vitreous band observed in the right eye at least once during the
imaging sessions. Comparing the infants who had a vitreous
band observed in the right eye at any time with those who did
not, no difference in mean birth weight, gestational age, postmenstrual age at imaging, sex, or race/ethnicity was identified (Table). The vitreous bands were distributed evenly with
respect to postmenstrual age at imaging and did not appear
to be associated with particular ages. Among those infants with
vitreous bands, concurrent clinical examination of the right
eye revealed ROP stage 0 for 13 of 24 infants (54%), stage 1 for
4 of 24 infants (17%), stage 2 for 1 of 24 infants (4%), and stage
3 for 6 of 24 infants (25%). No associations between the presence of a vitreous band and markers of ROP severity, including ROP stage 3 (eg, in 6 [25%] infants with vitreous bands vs
4 [10%] in those without; P = .23), plus disease (2 [8%] vs 2
[5%]; P = .84), and type 1 ROP (3 [12%] vs 3 [7%]; P = .66), were
identified. Among 10 of 209 imaging sessions (5%) in which a
vitreous finding was described by the clinician (6 of 65 infants [9%]), only 1 of 65 infants (2%) had coexisting vitreous
bands seen by SD-OCT (P = .43) (Table).
756

Image obtained from a study participant with stage 0 retinopathy of
prematurity, vascularized to zone 3. A hyperreflective band (arrowheads)
appeared to be hovering parallel to the retina in the right eye of 22 of 65
subjects (34%) screened for retinopathy of prematurity.

Discussion
Retinopathy of prematurity is a complex vasoproliferative
disease affecting both the retina and the vitreous. With the
increasing use of handheld SD-OCT among the infant population, we are now able to appreciate subclinical findings that
affect the retinal microarchitecture in premature infants.4-9
To our knowledge, this is the first comprehensive report on
vitreous findings documented by handheld SD-OCT among
infants screened for ROP.
Lee et al4 described “vitreous material shadowing” that
was seen in 7 of 207 handheld SD-OCT images from premature infants screened for ROP but did not describe the source
of the shadowing nor correlate the shadows to ROP stage. It is
possible that earlier studies overlooked subtle vitreous findings noted in this study. In this study, vitreous bands and punctate hyperreflective vitreous opacities occurred in 40 of 209
(19%) and 46 of 209 (22%) of the imaging sessions reviewed,
respectively, but they may not have a related cause because
they infrequently occurred together (9 of 209 imaging sessions [4%]; P = .26).
Our study showed an association between the development of a vitreous band and both CME and ERM. These findings support a tractional pathogenesis to these entities in
premature infants. Vinekar et al6 previously suggested that
CME of prematurity may be related to the mechanical traction exerted on the macula. Other studies have associated CME
with worsening ROP severity.6,27
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Figure 3. Handheld Spectral-Domain Optical Coherence Tomography
Image of a Vitreous Tractional Band

Original Investigation Research

Table. Demographic Characteristics, Clinical Examination Findings,
and Imaging Characteristics of 65 Premature Infants Screened for ROP
No. (%) of Infants

Characteristic

No Vitreous
Band
(n = 41)

Vitreous
Band
(n = 24)a

Demographic characteristic
Male
Birth weight, mean (SD), g

22 (55)

11 (46)

974 (281)

1039 (297)

Gestational age, mean (SD), wk

28.2 (3.0)

27.6 (2.0)

Postmenstrual age at imaging,
mean (SD), wk

34.3 (3.2)

34.3 (2.5)

11 (46)

25 (61)

Race/ethnicity
White
Hispanic

4 (17)

6 (15)

Native American

1 (4)

2 (5)

African American

1 (4)

0

Pacific Islander

1 (4)

0

Asian

2 (8)

1 (2)

Otherb

4 (17)

4 (10)

ROP stage 0

30 (73)

13 (54)

ROP stage 1

4 (10)

4 (17)

ROP stage 2

3 (7)

1 (4)

ROP stage 3

4 (10)

6 (25)

Plus disease

2 (5)

2 (8)

Type 1 ROP

3 (7)

3 (12)

Vitreous haze

5 (21)

1 (4)

Indirect ophthalmic examination findings
Image obtained from an infant with stage 3 retinopathy of prematurity.
A hyperreflective band (arrowheads) approaches at a steep angle, connecting
with the retina near the fovea. This type of band was seen in 5 of 65 participants
(8%). Note the numerous punctate hyperreflective vitreous opacities.

Among infants with ROP who are at risk for retinal detachment, there are known tractional vectors in the vitreous. These
bands are targeted during vitrectomy for stage 4 ROP.28 In histologic studies of membranes removed during vitreoretinal surgery to treat ROP-related retinal detachment, researchers found
that the internal limiting membrane was fragmented by retinal glial cells that migrated into the vitreous.29 Vitreous bands
observed on handheld SD-OCT may represent the hyaloidal organization of vitreous membranes formed by retinal glial cells,
which rarely leads to retinal detachment in advanced ROP.
According to our data, there was no significant association between the development of a vitreous band and worsening
ROP stage. However, because tractional bands are clinically observed in advanced stages of peripheral ROP,10 it is possible
that the limited peripheral scanning ability of the SD-OCT may
have resulted in missing a large proportion of these tractional
bands. Nonetheless, the few central tractional bands identified in this study may suggest diffuse vitreous changes
predisposing these infants to advanced ROP.
We hypothesize that our understanding of diabetic vitreoretinopathy can serve as a parallel disease model for similar
vitreous changes and interactions at the vitreoretinal interface among infants with ROP. Earlier studies on diabetic retinopathy have detailed the development of a vitreoschisis cavity, which serves as a scaffold for migrating retinal glial and
inflammatory cells leading to nontractional bands. These
changes, in turn, create a thickened and taut posterior vitreous cortex that eventually contributes to both CME and ERM.30
Although chronically elevated vascular endothelial growth
factor levels may further contribute to prolonged CME in
diabetic retinopathy, CME in premature infants appears to be
self-limited.6 The role of subsequent vitreous changes in
jamaophthalmology.com

SD-OCT findings
Punctate hyperreflective vitreous opacities

10 (24)

9 (38)

Cystoid macular edema

11 (27)

15 (62)

6 (15)

15 (62)

Epiretinal membrane

Abbreviations: ROP, retinopathy of prematurity; SD-OCT, spectral-domain
optical coherence tomography.
a

Infant was categorized as having a vitreous band if he or she ever had a
vitreous band, including tractional and nontractional vitreous bands, detected
in the right eye using handheld SD-OCT at any point throughout ROP
screening.

b

Patients who did not have a race/ethnicity identified in their medical record.

CME resolution in premature infants is unknown. Longer
follow-up is needed.

Limitations
Our study was limited by its observational study design and
short study follow-up. Nonetheless, we had a high interobserver agreement for SD-OCT findings.

Conclusions
To our knowledge, this was the first study to identify an association between vitreous bands and retinal pathologic features including CME and ERM, providing important clues toward understanding the pathophysiology of ROP and visual
impairment in premature infants. Whether any of these findings lead to poor visual or refractive outcomes deserves
additional research.
(Reprinted) JAMA Ophthalmology July 2018 Volume 136, Number 7
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examination of premature infants for retinopathy of
prematurity. Pediatrics. 2013;131(1):189-195.
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